Il-1 trap (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 266 | 家族性地中海熱 | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00582907 (ClinicalTrials.gov) | August 2008 | 19/12/2007 | Rilonacept for Treatment of Familial Mediterranean Fever (FMF) | Phase 2 Study of IL-1 Trap (Rilonacept) for Treatment of Familial Mediterranean Fever (FMF) | Familial Mediterranean Fever | Drug: Rilonacept;Drug: Placebo | The Cleveland Clinic | NULL | Completed | 4 Years | N/A | All | 14 | Phase 2 | United States |
| 2 | NCT00094900 (ClinicalTrials.gov) | October 2004 | 28/10/2004 | Interleukin-1 Trap to Treat Autoinflammatory Diseases | Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects With Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis | Inflammation;Familial Mediterranean Fever;Still's Disease, Adult-Onset | Drug: IL-1 Trap | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | NULL | Completed | 18 Years | N/A | All | 11 | Phase 2 | United States |